Результати пошуку - Yuichiro Iwamoto

  • Показ 1 - 7 результатів із 7
Уточнити результати
  1. 1
    Tay–Sachs disease mutations in HEXA target the α chain of hexosaminidase A to endoplasmic reticulum–associated degradation

    Tay–Sachs disease mutations in HEXA target the α chain of hexosaminidase A to endoplasmic reticulum–associated degradation за авторством Devin Dersh, Yuichiro Iwamoto, Yair Argon

    Опубліковано 2016
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  2. 2
    How HIV Nef Proteins Hijack Membrane Traffic To Promote Infection

    How HIV Nef Proteins Hijack Membrane Traffic To Promote Infection за авторством Cosmo Z. Buffalo, Yuichiro Iwamoto, James H. Hurley, Xuefeng Ren

    Опубліковано 2019
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  3. 3
    Clinical outcomes of endocrine and other disorders induced by immune checkpoint inhibitors in Japanese patients

    Clinical outcomes of endocrine and other disorders induced by immune checkpoint inhibitors in Japanese patients за авторством Yuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto

    Опубліковано 2025
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    Clustering of IRE1α depends on sensing ER stress but not on its RNase activity

    Clustering of IRE1α depends on sensing ER stress but not on its RNase activity за авторством Daniela Ricci, Ilaria Marrocco, Daniel Blumenthal, Miriam Dibos, Daniela Eletto, Jade Vargas, Sarah A. Boyle, Yuichiro Iwamoto, Steven Chomistek, James C. Paton, Adrienne W. Paton, Yair Argon

    Опубліковано 2019
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  5. 5
    Efficacy and safety analysis according to histology for S-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: updated results of the West Japan Oncology Group LETS study

    Efficacy and safety analysis according to histology for S-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: updated... за авторством Hiroshige Yoshioka, Isamu Okamoto, Satoshi Morita, Masahiko Ando, Kazuhisa Takeda, Takashi Seto, Nobuyuki Yamamoto, Hideo Saka, Shinji Atagi, T. Hirashima, Satoshi Kudoh, Miyako Satouchi, Norihiko Ikeda, Yuichiro Iwamoto, Toshiyuki Sawa, Yoichi Nakanishi, Kazuhiko Nakagawa

    Опубліковано 2013
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L

    A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L за авторством Fumihiko Hirai, Takeharu Yamanaka, Kenichi Taguchi, H. Daga, Akira Ono, Kaoru Tanaka, Yoshihito Kogure, Junichi Shimizu, Tatsuo Kimura, Junya Fukuoka, Yuichiro Iwamoto, H Sasaki, Koji Takeda, Takashi Seto, Y. Ichinose, Kazuhiko Nakagawa, Yoichi Nakanishi

    Опубліковано 2014
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    Open-label phase II study of the efficacy of nivolumab for cancer of unknown primary

    Open-label phase II study of the efficacy of nivolumab for cancer of unknown primary за авторством Junko Tanizaki, Kan Yonemori, Kohei Akiyoshi, Hironobu Minami, Hiroki Ueda, Yuichi Takiguchi, Yuji Miura, Yoshihiko Segawa, Shin Takahashi, Yuichiro Iwamoto, Yasuhiro Kidera, K. Fukuoka, Akinori Ito, Yasutaka Chiba, Kazuko Sakai, Kazuto Nishio, Kazuhiko Nakagawa, Hidetoshi Hayashi

    Опубліковано 2021
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: